Systemic Endotoxemia as the driver of chronic inflammation - Biomarkers and novel therapeutic targets for Arthritis

Projektinformationen

ENDOTARGET

ID Finanzhilfevereinbarung: 101095084

DOI

10.3030/101095084

EK-Unterschriftsdatum 15 November 2022

Startdatum 1 Januar 2023

Enddatum 31 Dezember 2026

Finanziert unter

• Health

Gesamtkosten

€ 6 997 820,00

EU-Beitrag

€ 6 997 820,00

Koordiniert durch

HUS-YHTYMA
Finland

CORDIS bietet Links zu öffentlichen Ergebnissen und Veröffentlichungen von HORIZONT-Projekten.

Links zu Ergebnissen und Veröffentlichungen von RP7-Projekten sowie Links zu einigen Typen spezifischer Ergebnisse wie Datensätzen und Software werden dynamisch von OpenAIRE abgerufen.

Leistungen

Websites, patent fillings, videos etc. (1)

Project website

Endotargets central web presence including detailed overview on the consortium and its research activities

Documents, reports (3)

First version of dissemination and communication plan

Outline of Endotarget’s dissemination and communication strategy including planned D&C activities.

Project handbook

All relevant project related information for the consortium will be collected in project handbookIt includes general information of agreements project organizational structure communication and dissemination practices internal reviewprocess of deliverables and payments for example

Risk Management plan

Deliverable will include the processes, tools and procedures that will be used to manage and control those events within the Endotarget project that could have a negative impact. It will expose the proposed risk management approach of the project for managing and controlling all project risks. Deliverable will be updated throughout the project.

Data Management Plan (1)

Data Management Plan

Data Management Plan (DMP) of Endotarget’s is to identify the project’s research data and to describe how to make them findable, accessible, interoperable and re-usable (FAIR)

Veröffentlichungen

Peer reviewed articles (4)

β Boswellic Acid Blocks Articular Innate Immune Responses: An In Silico and In Vitro Approach to Traditional Medicine

Autoren: Eloi Franco-Trepat; Ana Alonso-Pérez; María Guillán-Fresco; Miriam López-Fagúndez; Andrés Pazos-Pérez; Antía Crespo-Golmar; Susana Belén Bravo; Verónica López-López; Alberto Jorge-Mora; José P. Cerón-Carrasco; Ana Lois Iglesias; Rodolfo Gómez
Veröffentlicht in: Antioxidants, 2023, ISSN 2076-3921
Herausgeber: MDPI
DOI: 10.3390/antiox12020371

The Hepatokine RBP4 Links Metabolic Diseases to Articular Inflammation

Autoren: Andrés Pazos-Pérez, María Piñeiro-Ramil, Eloi Franco-Trepat, Ana Alonso-Pérez, María Guillán-Fresco, Antía Crespo-Golmar, Miriam López-Fagúndez, Javier Conde Aranda, Susana Belen Bravo, Alberto Jorge-Mora and Rodolfo Gómez
Veröffentlicht in: Antioxidants, 2024, ISSN 2076-3921
Herausgeber: MDPI
DOI: 10.3390/antiox13010124

Beyond Seasoning—The Role of Herbs and Spices in Rheumatic Diseases

Autoren: Charneca, Sofia; Hernando, Ana; Costa-Reis, Patricia; Guerreiro, Catarina Sousa
Veröffentlicht in: Nutrients, 2023, ISSN 2072-6643
Herausgeber: MDPI
DOI: 10.3390/nu15122812

Formononetin, a Beer Polyphenol with Catabolic Effects on Chondrocytes

Autoren: María Guillán-Fresco; Eloi Franco-Trepat; Ana Alonso-Pérez; Alberto Jorge-Mora; Verónica López-López; Andrés Pazos-Pérez; María Piñeiro-Ramil; Rodolfo Gómez
Veröffentlicht in: Nutrients, 2023, ISSN 2072-6643
Herausgeber: MDPI
DOI: 10.3390/nu15132959